EADV report shows that risankizumab is a consistent performer in psoriasis
Risankizumab performed better in treating psoriasis that appears on the nails, hands and feet, palms and scalp sores.
EADV starts this week in Paris
The European Academy of Dermatology and Venerology (EADV) 2018 meeting takes this week in Paris. Visit our EADV conference news site to follow the developments from Paris.
Fall Clinical PA/NP 2025: Familiar Faces to Dermatology Times
Daily Derm Times: May 29, 2025
Dermatology Times May 2025 Print Recap
Top 5 Articles of the Month: May
